(Q37818148)

23 August 2017

1 reference

title

Pharmacokinetic interactions between etravirine and non-antiretroviral drugs (English)

1 reference

23 August 2017

main subject

anti-retroviral agent

0 references

etravirine

1 reference

ChEBI release 2020-05-28

1 reference

1

0 references

author name string

Monika Schöller-Gyüre

series ordinal

2

1 reference

23 August 2017

Richard M W Hoetelmans

series ordinal

3

1 reference

23 August 2017

language of work or name

1 reference

1 January 2011

1 reference

Clinical Pharmacokinetics

23 August 2017

published in

1 reference

23 August 2017

volume

50

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

25-39

1 reference

Metabolism of antiarrhythmics

23 August 2017

cites work

1 reference

12 December 2020

In vitro metabolism of dexamethasone (DEX) in human liver and kidney: the involvement of CYP3A4 and CYP17 (17,20 LYASE) and molecular modelling studies

1 reference

12 December 2020

Efficacy and safety of etravirine at week 96 in treatment-experienced HIV type-1-infected patients in the DUET-1 and DUET-2 trials

1 reference

12 December 2020

Methadone--metabolism, pharmacokinetics and interactions

1 reference

12 December 2020

The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy.

1 reference

12 December 2020

Clinical pharmacokinetics of fibric acid derivatives (fibrates).

1 reference

12 December 2020

Effect of simultaneous induction and inhibition of CYP3A by St John's Wort and ritonavir on CYP3A activity

1 reference

12 December 2020

Macrolide drug interactions: an update

1 reference

12 December 2020

Clinically relevant drug interactions with antiepileptic drugs

1 reference

12 December 2020

Issues in drug metabolism of major antihypertensive drugs: beta-blockers, calcium channel antagonists and angiotensin receptor blockers

1 reference

12 December 2020

Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance

1 reference

12 December 2020

Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic study of the concomitant administration of methadone and TMC125 in HIV-negative volunteers

1 reference

12 December 2020

A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV-negative volunteers

1 reference

12 December 2020

TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1.

1 reference

12 December 2020

Single- and multiple-dose pharmacokinetics of etravirine administered as two different formulations in HIV-1-infected patients.

1 reference

12 December 2020

The effect of ethinyloestradiol and levonorgestrel on the CYP2C19-mediated metabolism of omeprazole in healthy female subjects

1 reference

12 December 2020

Drug interactions between HIV protease inhibitors and acid-reducing agents.

1 reference

12 December 2020

Clinical perspective on antiretroviral drug-drug interactions with the non-nucleoside reverse transcriptase inhibitor etravirine.

1 reference

12 December 2020

Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials

1 reference

12 December 2020

Drug-drug interactions of antifungal agents and implications for patient care

1 reference

12 December 2020

Pharmacokinetic interactions with rifampicin : clinical relevance

1 reference

12 December 2020

Effect of a triphasic oral contraceptive on drug-metabolizing enzyme activity as measured by the validated Cooperstown 5+1 cocktail

1 reference

12 December 2020

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

1 reference

12 December 2020

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Assessment of the steady-state pharmacokinetic interaction between etravirine administered as two different formulations and tenofovir disoproxil fumarate in healthy volunteers

1 reference

12 December 2020

Clinical pharmacokinetics of contraceptive steroids. An update

1 reference

12 December 2020

Pharmacokinetics of darunavir/ritonavir and TMC125 alone and coadministered in HIV-negative volunteers

1 reference

12 December 2020

Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of the non-nucleoside reverse-transcriptase inhibitor etravirine in treatment-experienced HIV-1-infected patients.

1 reference

12 December 2020

Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4

1 reference

12 December 2020

Design of antiretroviral drug interaction studies.

1 reference

12 December 2020

Midazolam and other benzodiazepines

1 reference

12 December 2020

Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials

1 reference

12 December 2020

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update

1 reference

12 December 2020

Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans

1 reference

12 December 2020

Clinical pharmacokinetics and pharmacodynamics of etravirine

1 reference

12 December 2020

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Effect of steady-state etravirine on the pharmacokinetics and pharmacodynamics of ethinylestradiol and norethindrone.

1 reference

12 December 2020

Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms

1 reference

12 December 2020

Human buprenorphine N-dealkylation is catalyzed by cytochrome P450 3A4.

1 reference

12 December 2020

Pharmacokinetic interactions between buprenorphine and antiretroviral medications

1 reference

12 December 2020

10.2165/11534740-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

23 August 2017

1035615167

0 references

1 reference